My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.

    Gaster M, Rustan AC, Aas V, Beck-Nielsen H.

    Diabetes. 2004 Mar;53(3):542-8.PMID: 14988236 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.

    Gaster M, Rustan AC, Beck-Nielsen H.

    Diabetes. 2005 Mar;54(3):648-56.PMID: 15734839 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.

    Gaster M, Beck-Nielsen H.

    Biochim Biophys Acta. 2006 Jan;1761(1):100-10. Epub 2006 Jan 18.PMID: 16442843 [PubMed - indexed for MEDLINE]Related articles

    4.

    The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.

    Gaster M, Beck-Nielsen H.

    Biochim Biophys Acta. 2004 Sep 6;1690(1):85-91.PMID: 15337174 [PubMed - indexed for MEDLINE]Related articles

    5.

    Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid.

    Wensaas AJ, Rustan AC, Just M, Berge RK, Drevon CA, Gaster M.

    Diabetes. 2009 Mar;58(3):527-35. Epub 2008 Dec 9.PMID: 19066312 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects.

    Just M, Faergeman NJ, Knudsen J, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2006 Jul;1762(7):666-72. Epub 2006 May 23.PMID: 16815692 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.

    Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M.

    Biochim Biophys Acta. 2005 Jun 30;1741(1-2):206-14. Epub 2005 Apr 22.PMID: 15894466 [PubMed - indexed for MEDLINE]Related articles

    8.

    Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.

    Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC.

    J Lipid Res. 2006 Feb;47(2):366-74. Epub 2005 Nov 21.PMID: 16301737 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.

    Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ.

    J Appl Physiol. 2006 May;100(5):1467-74. Epub 2005 Dec 15.PMID: 16357064 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.

    Gaster M.

    Biochem Biophys Res Commun. 2009 May 15;382(4):766-70. Epub 2009 Mar 24.PMID: 19324004 [PubMed - indexed for MEDLINE]Related articles

    11.

    The dynamic of lipid oxidation in human myotubes.

    Gaster M.

    Biochim Biophys Acta. 2009 Jan;1791(1):17-24. Epub 2008 Oct 8.PMID: 18952196 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?

    Vaag A, Alford F, Beck-Nielsen H.

    Diabet Med. 1996 Sep;13(9):806-15.PMID: 8891456 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?

    Gaster M.

    Biochem Biophys Res Commun. 2009 Oct 2;387(4):651-5. Epub 2009 Jul 16.PMID: 19615969 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.

    Bouzakri K, Roques M, Debard C, Berbe V, Rieusset J, Laville M, Vidal H.

    Diabetologia. 2004 Jul;47(7):1314-23. Epub 2004 Jun 26.PMID: 15292987 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells.

    Aas V, Kase ET, Solberg R, Jensen J, Rustan AC.

    Diabetologia. 2004 Aug;47(8):1452-61. Epub 2004 Jul 28.PMID: 15309295 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.

    Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB.

    Diabetologia. 2006 Sep;49(9):2144-52. Epub 2006 Jul 26.PMID: 16868746 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

    Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E151-9. Epub 2005 Feb 22.PMID: 15727952 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation.

    Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, Brown NF.

    J Biol Chem. 2004 Jun 25;279(26):27177-86. Epub 2004 Apr 22.PMID: 15105415 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.

    Kase ET, Thoresen GH, Westerlund S, Højlund K, Rustan AC, Gaster M.

    Diabetologia. 2007 Oct;50(10):2171-80. Epub 2007 Jul 28.PMID: 17661008 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity